Courtesy of Dr. Carlos Fava. In the last decades, there has been a marked increase in the use bioprosthetic valves in aortic position given their benefits over mechanical valves. However, long term follow-up has shown structural valve degeneration (SVD). Given the risk of a second surgery after TAVR, valve-in-valve (ViV) has been on the rise,<a href="https://solaci.org/en/2020/08/19/valve-in-valve-good-evolution-at-long-term/" title="Read more" >...</a>
Courtesy of Dr. Carlos Fava. DES have improved PCI outcomes, but one of its biggest challenges continues to be bifurcations (especially when we have to use two stents, since it’s been associated to higher restenosis and stent thrombosis rates). Left main coronary artery true bifurcation lesions are the ones that generate the greatest challenge and<a href="https://solaci.org/en/2020/07/28/two-stent-strategy-is-safer-in-true-bifurcation-lesions/" title="Read more" >...</a>
SOLACI’s Department of Peripheral Endovascular Interventions is promoting the analysis of challenging clinical cases on peripheral interventions so as to foster the participation and engagement of all SOLACI members. In this first issue, we present a clinical case around carotid artery stenting. Read thoroughly the case below and take part in an unrestricted discussion through<a href="https://solaci.org/en/2020/06/17/solaci-peripheral-clinical-case-discussion/" title="Read more" >...</a>
Check out the main topics of the upcoming SOLACI-CACI 2021 Congress. Save the Date! Special Session About the COVID-19 Pandemic Managing Cardiovascular disease and Cath Lab during the COVID-19 Pandemic Live Case Transmissions Coronary and Structural cases performed by distinguished international and national operators. Coronary Track Myocardial Infarction, Left Main session, Complex<a href="https://solaci.org/en/2020/06/09/solaci-caci-2021-preliminary-agenda/" title="Read more" >...</a>
This prospective study analyzed patients with critical lower limb ischemia (due to complex, multiple lesions in several places) who were treated uniformly with common femoral artery endarterectomy combined with angioplasty to improve inflow and/or outflow. This hybrid treatment, which must be carried out by a team, can be greatly beneficial for this high-risk patient group<a href="https://solaci.org/en/2020/05/26/common-femoral-artery-endarterectomy-plus-angioplasty-in-critical-ischemia/" title="Read more" >...</a>
Preventing coronary artery obstruction during transcatheter aortic valve replacement (TAVR) continues to be a challenge. There are techniques to prevent (or at least reduce) this from happening, which could be catastrophic. However, they all somehow fall into palliative care, that is, they will merely provide relief, rather than a cure. Commissure overlapping and the resulting<a href="https://solaci.org/en/2020/05/26/aligning-prosthetic-valves-to-native-commissures-the-secret-to-coronary-artery-obstruction/" title="Read more" >...</a>
The 40th Regional Sessions held in Ecuador in 2020 was a successful scientific event that counted with the participation of reputed Latin American interventionists. We want to express our gratitude to all participants, attendees and representatives of the industry who contributed to the highest quality of this event. Next, we share some of the presentations<a href="https://solaci.org/en/2020/04/13/ecuador-regional-sessions-2020-see-the-presentations/" title="Read more" >...</a>
Three generations of self-expanding valves, three different prognoses for our patients. Design improvements and better materials in self-expanding, supra-annular aortic valves, and their better results, have allowed for the expansion of the indication for transcatheter aortic valve replacement (TAVR). Particularly, the addition of a pericardial skirt improves annular sealing and results in a significantly low<a href="https://solaci.org/en/2020/04/08/technological-improvements-in-valves-translate-into-clinical-results/" title="Read more" >...</a>
Nearly all prostheses for transcatheter aortic valve replacement (TAVR) commercially available at present are adequate for most patients. However, there are certain subgroups, relatively small, that could benefit from a particular one. Yesterday we went over the best suited for small annuli, which turned out to be the self-expandable in general and the Evolut PRO<a href="https://solaci.org/en/2020/03/20/tavr-in-extremely-large-annuli-different-patients-might-need-different-prostheses/" title="Read more" >...</a>
Courtesy of Dr. Carlos Fava. There a few treatment options for tricuspid valve disease. It is practically limited to diuretics and surgery, is associated to high mortality and, generally, mitral regurgitation. Developing the “edge-to-edge” strategy with MitraClip has been shown beneficial and, at present, there are studies that claim this technique could be greatly beneficial<a href="https://solaci.org/en/2020/03/10/treating-both-atrial-valves-improves-survival/" title="Read more" >...</a>